A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

NCT04320615 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

452

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Tocilizumab (TCZ)
DRUG: Placebo

Sponsor

Hoffmann-La Roche